Corneal transplantation in antibody-deficient hosts

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 1, 1999, Pages 250-253

  Goslings, Willem R O ^a,b   Yamada, Jun ^a   Dana, M Reza ^a   Streilein, J Wayne ^a   Van Beelen, Els ^c   Prodeus, Andrey P ^a   Carroll, Michael C ^a   Jager, Martine J ^c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GENETIC RECOMBINATION; GRAFT REJECTION; HOST; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; B-LYMPHOCYTES; COMPLEMENT C3; CORNEAL TRANSPLANTATION; GENES, IMMUNOGLOBULIN; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 0032909156     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med. 1990; 172:1547-1557.
2. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts, II: Importance of humoral immunity. J Immunol. 1994;152:5135-5141.
3. Brauer RB, Baldwin WM, Sanfilippo F. Evidence that terminal complement components contribute to acute allograft rejection. Transplantation. 1995;59:288-293.
4. Jager MJ, Völker-Dieben HJ, Vos A, et al. Cellular and humoral anticorneal immune response in comeal transplantation. Arch Ophthalmol. 1991;109:972-977.
5. Hutchinson IV, Alam Y, Ayliffe WR. The humoral response to an allograft. Eye. 1995;9:155-160.
6. Treseler PA, Sanfilippo F. Humoral immunity to heterotopic corneal allografts in the rat. Transplantation. 1985;39:193-196.
7. Hedge S, Hargrave S, Mellon J, Niederkorn JY. Antibody- and cell-mediated immune responses during rejection of a murine orthotopic corneal graft [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S455.
8. Hahn AB, Foulks GN, Enger C, et al. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation. 1995;59:21-27.
9. Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 1991;350:423-426.
10. Bruning JW, Claas FHJ, Kardol MJ, Lansbergen Q, Naipal AM, Tanke HJ. Automated reading of HLA-A,B,C typing and screening: the propidium iodide (PI) method. Hum Immunol. 1982;5:225-231.
11. Wessels MR, Butko P, Ma M, et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Prac Natl Acad Sci. 1995;92: 11490-11494.
12. Sonoda Y, Streilein JW. Urthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
13. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic comeal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.